Developer docs
API playgroundTry for free, no card

Search company profiles

University of Pittsburgh Health Sciences

Full company profile

uuid0002dg2

Namestring
University of Pittsburgh Health Sciences
Legal namestring
University of Pittsburgh Health Sciences
Websiteurl
health.pitt.edu
Company typeenum
Public
Founded yearint
1883
Descriptiontext

The University of Pittsburgh Health Sciences is the health-sciences division of the University of Pittsburgh, comprising six schools — Dental Medicine, Health and Rehabilitation Sciences, Medicine, Nursing, Pharmacy, and Public Health — that together deliver undergraduate, graduate, professional, and continuing health-sciences education alongside biomedical research and clinical services. The division supports 115+ research centers and institutes, including the McGowan Institute for Regenerative Medicine and the Human Engineering Research Laboratories, and holds 83 issued patents spanning regenerative medicine, AI diagnostics, and biomedical engineering. Notable technology platforms include an FDA-approved blood biomarker test for Alzheimer's disease (p-tau217 ratio) developed by the Karikari group, the RAMMP autonomous wheelchair and assistive robotic arm system integrating AI and digital twin technology, the HexAI Lab for orthopaedic imaging AI with built-in bias mitigation, and a cortical visual prosthesis program built on 1,024-electrode arrays (José-Alain Sahel, 2024 Wolf Prize in Medicine).

The institution operates a hybrid revenue model anchored in competitive research grants (federal, state, foundation, industry), tuition and fees across six academic programs, and clinical revenue delivered through its affiliation with UPMC. Major funding sources documented in the 2024–2026 period include the U.S. Department of Defense ($100M for trauma trials), ARPA-H (up to $41.5M for RAMMP), NIH ($626.7M total), the National Institute of Dental and Craniofacial Research ($17M for TMD pain), the Neuromod Prize competition ($3M), The Pittsburgh Foundation ($776K), and a $10M corporate investment from Leidos for healthcare AI tooling. Research expenditures exceed $1.3B annually and the division employs 5,001–10,000 people across Pittsburgh. Twenty or more faculty members are elected to the National Academy of Medicine, and the division is currently constructing an 185,000 sq ft Pitt BioForge biomanufacturing facility to extend the innovation pipeline into scaled precision-medicine production.

Short descriptiontext

University of Pittsburgh Health Sciences is the health-sciences division of the University of Pittsburgh, operating six schools that deliver biomedical education, research, and clinical services through its UPMC affiliation, backed by more than $1.5B in externally funded research.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersPittsburgh, United States
HQ citystring
Pittsburgh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health sciences education, biomedical research programs, clinical research services, regenerative medicine research, pharmaceutical sciences education
Industry1 code
1Health & Biomedical Research Universities (Academic Medical Center–Affiliated)
CodeEDAHABACPrimaryYes
NAICS code3 codes
  • Colleges, Universities, and Professional Schools6113
  • Colleges, Universities, and Professional Schools611310
  • Medical Laboratories621511
SIC code3 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
  • Surgical & Medical Instruments & Apparatus3841
Product category
Academic Health Sciences Education and Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Research grants and funding
TypeOthers
Description

Primary revenue through competitive research grants from federal agencies (Department of Defense, NIH, ARPA-H), state government, foundations, and industry partnerships. In 2024-2025, the institution received major grants including $100M from DoD for trauma trials and up to $41.5M from ARPA-H for robotic wheelchair development.

upmc.com
2Education and training programs
TypeSubscription Recurring
Description

Tuition and fees from six health sciences schools providing undergraduate, graduate, professional, and continuing education programs. Programs include medicine, nursing, pharmacy, dental medicine, public health, and health rehabilitation sciences.

health.pitt.edu
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

University of Pittsburgh Health Sciences delivers health sciences education across six schools (Dental Medicine, Health and Rehabilitation Sciences, Medicine, Nursing, Pharmacy, Public Health) along with biomedical and clinical research programs spanning aging, cancer immunotherapy, neuroscience, regenerative medicine, and infectious disease. Clinical services are delivered through the affiliated UPMC health system, while the McGowan Institute, Human Engineering Research Laboratories, and Pitt BioForge support technology development and commercialization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • NIH Funding: $626.7M to Pitt Health Sciences
+4 more records
Product overview1 text field

University of Pittsburgh Health Sciences operates as a multi-school research and education organization offering a portfolio of distinct health sciences products and research programs. The core offerings include advanced medical technologies (RAMMP wheelchair system, Alzheimer's blood test, depression therapy, artificial vision), research facilities (Pitt BioForge biomanufacturing, McGowan Institute, Human Engineering Research Laboratories), and specialized research initiatives (CREATE Study, HexAI Lab). These products range from FDA-approved diagnostic tools to experimental therapeutic approaches and AI-powered rehabilitation technologies.

Product and service12 records
1School of Dental Medicine Programs
CategoryHealth Sciences Education
Description

Undergraduate, professional, and graduate education and research in dental medicine, serving dental students, residents, and practicing dentists seeking advanced training.

2School of Health and Rehabilitation Sciences Programs
CategoryHealth Sciences Education
Description

Education and research programs in physical therapy, occupational therapy, communication science, and other rehabilitation sciences for students and clinicians.

3School of Medicine Programs
CategoryHealth Sciences Education
Description

MD education, residency training, graduate programs, and biomedical research serving medical students, residents, and physician-scientists.

4School of Nursing Programs
CategoryHealth Sciences Education
Description

BSN, MSN, DNP, and PhD nursing programs serving nursing students, nurse practitioners, and nurse researchers.

5School of Pharmacy Programs
CategoryHealth Sciences Education
Description

PharmD and graduate pharmaceutical sciences education serving pharmacy students, residents, and pharmaceutical researchers.

6School of Public Health Programs
CategoryHealth Sciences Education
Description

MPH, MS, and PhD public health programs serving public health students, practitioners, and researchers, with community health partnerships across Pennsylvania.

7RAMMP (Rehabilitation and Autonomous Mobility Modalities Platform)
CategoryRehabilitation Engineering
Description

Next-generation wheelchair and assistive robotic arm system integrating advanced robotics, artificial intelligence, a novel operating system, and digital twin technology for veterans and individuals with mobility impairments.

8Alzheimer's Blood Test
CategoryDiagnostic Testing
Description

FDA-approved diagnostic blood test measuring the ratio of modified tau protein (p-tau217) and amyloid beta peptide in plasma, enabling earlier and less invasive detection of Alzheimer's disease.

9McGowan Institute for Regenerative Medicine Research
CategoryRegenerative Medicine Research
Description

Research institute developing regenerative medicine approaches including ECM biomaterial technology for muscle regeneration, wound repair, and tissue engineering across preclinical and translational programs.

10Human Engineering Research Laboratories (HERL) Research
CategoryRehabilitation Engineering
Description

Research laboratory developing advanced rehabilitation technologies, including assistive robotics and mobility platforms, with VA clinical partnership for veterans with disabilities.

11Pitt BioForge Biomanufacturing Facility
CategoryBiomanufacturing Services
Description

Biomanufacturing facility enabling precision biomedical manufacturing innovation for startups, researchers, and industry partners developing advanced therapies.

12CREATE Study on Temporomandibular Disorders
CategoryClinical Research Study
Description

Comprehensive research study combining brain imaging, RNA sequencing, and microbiome analysis to understand and treat temporomandibular disorder pain across diverse patient cohorts.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierMajorTypeTechnology or IntegrationAnnounced on2026-04-01
Description

AWS powers Pitt's Claude for Education in Health Sciences and Sports Analytics Cloud Innovation Center for student-faculty-industry AI collaboration

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-26
Description

Pitt Public Health and Allegheny County Health Department created an academic public health department expanding collaboration in teaching, research, service and community health practice

3Pennsylvania One Health Consortium
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-26
Description

Coordinated by Pitt Public Health, the Pennsylvania One Health consortium makes connections across human, animal, and environmental health sectors

health.pitt.edu
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-10-20
Description

NAM elected three Pitt faculty members (Terence S. Dermody, John C. Byrd, Kate Rubins) recognizing outstanding professional achievement and commitment to service in health and medicine

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

ARPA-H awarded up to $41.5 million to develop RAMMP - next-generation wheelchair and assistive robotic arm system. Five-year project launched September 2025, led by HERL with Rory Cooper and Jorge Candiotti as coprincipal investigators.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Partnership with HERL for development of RAMMP robotic wheelchair and assistive technology. VA provides clinical sites and research collaboration for mobility and rehabilitation technology development.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-09-01
Description

Partner in national consortium for RAMMP robotic wheelchair project, contributing robotics expertise and technology integration

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Joint research on biomedical engineering, AI, and robotics. Partnership to train tomorrow's biomedical leaders. CMU is partner in RAMMP consortium for robotic wheelchair development.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-01
Description

Partner in RAMMP national consortium for robotic wheelchair project

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-01
Description

Partner in RAMMP national consortium for robotic wheelchair project

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-01
Description

Partner in RAMMP national consortium for robotic wheelchair project

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2025-09-01
Description

Partner in national consortium for RAMMP robotic wheelchair project, contributing mobility technology expertise

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-01
Description

Partner in RAMMP national consortium for assistive technology development

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-11-13
Description

MWRI awarded $1 million Magee Prize to Ronald Buckanovich's team for endometrial cancer research at the Magee-Womens Summit

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-09-24
Description

DoD awarded $100 million to support ongoing trauma trials and research and development in trauma treatment at the University of Pittsburgh

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Quintessentially comparable: a top-tier U.S. academic medical center with multiple health sciences schools (medicine, nursing, dental, etc.) under one administrative structure, deep NIH funding, and a similarly large research enterprise anchored to a major hospital system.

TypeDirect peer
Description

Closest direct peer in research scale and breadth: a research-intensive academic medical center with $1B+ in NIH funding, multiple health professional schools, and leadership in aging, neuroscience, cancer, and public health — areas where Pitt Health Sciences also competes.

TypeDirect peer
Description

Public-university academic health sciences division with similar structure (medical, nursing, pharmacy, dentistry schools) and comparable NIH funding scale, focused on biomedical research and clinical care delivery.

TypeDirect peer
Description

Comparable research-intensive academic medical enterprise with overlapping strengths in AI in healthcare, biomedical engineering, and translational research; competes for the same federal grants and faculty talent.

TypeDirect peer
Description

Research-intensive academic medical center with a top-ranked medical school and similar scale of NIH funding, biotech industry partnerships, and translational research pipeline.

TypeDirect peer
Description

Top-tier medical school with very high NIH funding per faculty, strong in neuroscience, aging, and biomedical research — directly comparable to Pitt's School of Medicine and McGowan Institute.

TypeDirect peer
Description

Academic medical center with multiple health sciences schools, deep NIH funding, and similarly large research base; comparable in scope across medicine, public health, and biomedical engineering.

TypeDirect peer
Description

Top-ranked medical school with NIH funding scale, strong biomedical research programs, and affiliation with a major hospital system — parallel in structure to Pitt/UPMC.

TypeDirect peer
Description

Academic medical center with comparable research enterprise, multi-school health sciences structure, and similarly strong translational research pipeline.

TypeDirect peer
Description

Public-university academic health sciences division with a comprehensive set of health professional schools, large externally funded research base, and broad biomedical and clinical research portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

University of Pittsburgh Health Sciences

Academic Health Sciences Education and Researchhealth.pitt.edu

University of Pittsburgh Health Sciences is the health-sciences division of the University of Pittsburgh, operating six schools that deliver biomedical education, research, and clinical services through its UPMC affiliation, backed by more than $1.5B in externally funded research.

What University of Pittsburgh Health Sciences does

The University of Pittsburgh Health Sciences is the health-sciences division of the University of Pittsburgh, comprising six schools — Dental Medicine, Health and Rehabilitation Sciences, Medicine, Nursing, Pharmacy, and Public Health — that together deliver undergraduate, graduate, professional, and continuing health-sciences education alongside biomedical research and clinical services. The division supports 115+ research centers and institutes, including the McGowan Institute for Regenerative Medicine and the Human Engineering Research Laboratories, and holds 83 issued patents spanning regenerative medicine, AI diagnostics, and biomedical engineering. Notable technology platforms include an FDA-approved blood biomarker test for Alzheimer's disease (p-tau217 ratio) developed by the Karikari group, the RAMMP autonomous wheelchair and assistive robotic arm system integrating AI and digital twin technology, the HexAI Lab for orthopaedic imaging AI with built-in bias mitigation, and a cortical visual prosthesis program built on 1,024-electrode arrays (José-Alain Sahel, 2024 Wolf Prize in Medicine).

The institution operates a hybrid revenue model anchored in competitive research grants (federal, state, foundation, industry), tuition and fees across six academic programs, and clinical revenue delivered through its affiliation with UPMC. Major funding sources documented in the 2024–2026 period include the U.S. Department of Defense ($100M for trauma trials), ARPA-H (up to $41.5M for RAMMP), NIH ($626.7M total), the National Institute of Dental and Craniofacial Research ($17M for TMD pain), the Neuromod Prize competition ($3M), The Pittsburgh Foundation ($776K), and a $10M corporate investment from Leidos for healthcare AI tooling. Research expenditures exceed $1.3B annually and the division employs 5,001–10,000 people across Pittsburgh. Twenty or more faculty members are elected to the National Academy of Medicine, and the division is currently constructing an 185,000 sq ft Pitt BioForge biomanufacturing facility to extend the innovation pipeline into scaled precision-medicine production.

University of Pittsburgh Health Sciences firmographics

Firmographics
Name
University of Pittsburgh Health Sciences
Legal name
University of Pittsburgh Health Sciences
Website
https://health.pitt.edu
Company type
Public
Founded year
1883
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
University of Pittsburgh Health Sciences is the health-sciences division of the University of Pittsburgh, operating six schools that deliver biomedical education, research, and clinical services through its UPMC affiliation, backed by more than $1.5B in externally funded research.
Ownership category
akta.pro rank

University of Pittsburgh Health Sciences industry classification

Industry
Product category
Academic Health Sciences Education and Research
NAICS
Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310), Medical Laboratories (621511)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC)

Keywords

  • Health sciences education
  • Biomedical research programs
  • Clinical research services
  • Regenerative medicine research
  • Pharmaceutical sciences education

Where University of Pittsburgh Health Sciences is headquartered

Location

Headquarters

HQ city
Pittsburgh
HQ country
United States
HQ region
North America

Offices1 record

Markets served

University of Pittsburgh Health Sciences business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Research grants and funding: Primary revenue through competitive research grants from federal agencies (Department of Defense, NIH, ARPA-H), state government, foundations, and industry partnerships. In 2024-2025, the institution received major grants including $100M from DoD for trauma trials and up to $41.5M from ARPA-H for robotic wheelchair development.
  2. Education and training programs: Tuition and fees from six health sciences schools providing undergraduate, graduate, professional, and continuing education programs. Programs include medicine, nursing, pharmacy, dental medicine, public health, and health rehabilitation sciences.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

University of Pittsburgh Health Sciences product offering

Product offering

Core offering

University of Pittsburgh Health Sciences delivers health sciences education across six schools (Dental Medicine, Health and Rehabilitation Sciences, Medicine, Nursing, Pharmacy, Public Health) along with biomedical and clinical research programs spanning aging, cancer immunotherapy, neuroscience, regenerative medicine, and infectious disease. Clinical services are delivered through the affiliated UPMC health system, while the McGowan Institute, Human Engineering Research Laboratories, and Pitt BioForge support technology development and commercialization.

Product overview

University of Pittsburgh Health Sciences operates as a multi-school research and education organization offering a portfolio of distinct health sciences products and research programs. The core offerings include advanced medical technologies (RAMMP wheelchair system, Alzheimer's blood test, depression therapy, artificial vision), research facilities (Pitt BioForge biomanufacturing, McGowan Institute, Human Engineering Research Laboratories), and specialized research initiatives (CREATE Study, HexAI Lab). These products range from FDA-approved diagnostic tools to experimental therapeutic approaches and AI-powered rehabilitation technologies.

Differentiator

Problem solved

Functional benefit

Products and services

  • School of Dental Medicine Programs Undergraduate, professional, and graduate education and research in dental medicine, serving dental students, residents, and practicing dentists seeking advanced training.
  • School of Health and Rehabilitation Sciences Programs Education and research programs in physical therapy, occupational therapy, communication science, and other rehabilitation sciences for students and clinicians.
  • School of Medicine Programs MD education, residency training, graduate programs, and biomedical research serving medical students, residents, and physician-scientists.
  • School of Nursing Programs BSN, MSN, DNP, and PhD nursing programs serving nursing students, nurse practitioners, and nurse researchers.
  • School of Pharmacy Programs PharmD and graduate pharmaceutical sciences education serving pharmacy students, residents, and pharmaceutical researchers.
  • School of Public Health Programs MPH, MS, and PhD public health programs serving public health students, practitioners, and researchers, with community health partnerships across Pennsylvania.
  • RAMMP (Rehabilitation and Autonomous Mobility Modalities Platform) Next-generation wheelchair and assistive robotic arm system integrating advanced robotics, artificial intelligence, a novel operating system, and digital twin technology for veterans and individuals with mobility impairments.
  • Alzheimer's Blood Test FDA-approved diagnostic blood test measuring the ratio of modified tau protein (p-tau217) and amyloid beta peptide in plasma, enabling earlier and less invasive detection of Alzheimer's disease.
  • McGowan Institute for Regenerative Medicine Research Research institute developing regenerative medicine approaches including ECM biomaterial technology for muscle regeneration, wound repair, and tissue engineering across preclinical and translational programs.
  • Human Engineering Research Laboratories (HERL) Research Research laboratory developing advanced rehabilitation technologies, including assistive robotics and mobility platforms, with VA clinical partnership for veterans with disabilities.
  • Pitt BioForge Biomanufacturing Facility Biomanufacturing facility enabling precision biomedical manufacturing innovation for startups, researchers, and industry partners developing advanced therapies.
  • CREATE Study on Temporomandibular Disorders Comprehensive research study combining brain imaging, RNA sequencing, and microbiome analysis to understand and treat temporomandibular disorder pain across diverse patient cohorts.

Quantifiable outcome

  • NIH Funding: $626.7M to Pitt Health Sciences
  • +4 more outcomes

Companies that use University of Pittsburgh Health Sciences

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

University of Pittsburgh Health Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature5 records

University of Pittsburgh Health Sciences partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered major, core and flagship.

  • AWS (Amazon Web Services)majorTechnology or Integration · 1 April 2026AWS powers Pitt's Claude for Education in Health Sciences and Sports Analytics Cloud Innovation Center for student-faculty-industry AI collaboration
  • Allegheny County Health DepartmentcoreStrategic or Co-development Partner · 26 February 2026Pitt Public Health and Allegheny County Health Department created an academic public health department expanding collaboration in teaching, research, service and community health practice
  • Pennsylvania One Health ConsortiumcoreStrategic or Co-development Partner · 26 February 2026Coordinated by Pitt Public Health, the Pennsylvania One Health consortium makes connections across human, animal, and environmental health sectors
  • National Academy of MedicinemajorStrategic or Co-development Partner · 20 October 2025NAM elected three Pitt faculty members (Terence S. Dermody, John C. Byrd, Kate Rubins) recognizing outstanding professional achievement and commitment to service in health and medicine
  • ARPA-H (Advanced Research Projects Agency for Health)flagshipStrategic or Co-development Partner · 1 September 2025ARPA-H awarded up to $41.5 million to develop RAMMP - next-generation wheelchair and assistive robotic arm system. Five-year project launched September 2025, led by HERL with Rory Cooper and Jorge Candiotti as coprincipal investigators.
  • U.S. Department of Veterans AffairsflagshipStrategic or Co-development Partner · 1 September 2025Partnership with HERL for development of RAMMP robotic wheelchair and assistive technology. VA provides clinical sites and research collaboration for mobility and rehabilitation technology development.
  • Kinova RoboticsmajorTechnology or Integration · 1 September 2025Partner in national consortium for RAMMP robotic wheelchair project, contributing robotics expertise and technology integration
  • Carnegie Mellon UniversitymajorStrategic or Co-development Partner · 1 September 2025Joint research on biomedical engineering, AI, and robotics. Partnership to train tomorrow's biomedical leaders. CMU is partner in RAMMP consortium for robotic wheelchair development.
  • Cornell UniversitycoreTechnology or Integration · 1 September 2025Partner in RAMMP national consortium for robotic wheelchair project
  • Northeastern UniversitycoreTechnology or Integration · 1 September 2025Partner in RAMMP national consortium for robotic wheelchair project
  • Purdue UniversitycoreTechnology or Integration · 1 September 2025Partner in RAMMP national consortium for robotic wheelchair project
  • LUCI MobilitymajorTechnology or Integration · 1 September 2025Partner in national consortium for RAMMP robotic wheelchair project, contributing mobility technology expertise
  • ATDevcoreTechnology or Integration · 1 September 2025Partner in RAMMP national consortium for assistive technology development
  • Magee-Womens Research InstituteflagshipStrategic or Co-development Partner · 13 November 2024MWRI awarded $1 million Magee Prize to Ronald Buckanovich's team for endometrial cancer research at the Magee-Womens Summit
  • U.S. Department of DefenseflagshipStrategic or Co-development Partner · 24 September 2024DoD awarded $100 million to support ongoing trauma trials and research and development in trauma treatment at the University of Pittsburgh

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

University of Pittsburgh Health Sciences competitors and assessment

Company assessment

Direct peers

  • University of Pennsylvania Health System (Penn Medicine): Quintessentially comparable: a top-tier U.S. academic medical center with multiple health sciences schools (medicine, nursing, dental, etc.) under one administrative structure, deep NIH funding, and a similarly large research enterprise anchored to a major hospital system.
  • Johns Hopkins Medicine: Closest direct peer in research scale and breadth: a research-intensive academic medical center with $1B+ in NIH funding, multiple health professional schools, and leadership in aging, neuroscience, cancer, and public health — areas where Pitt Health Sciences also competes.
  • UCSF Health / UCSF School of Medicine: Public-university academic health sciences division with similar structure (medical, nursing, pharmacy, dentistry schools) and comparable NIH funding scale, focused on biomedical research and clinical care delivery.
  • Stanford Medicine: Comparable research-intensive academic medical enterprise with overlapping strengths in AI in healthcare, biomedical engineering, and translational research; competes for the same federal grants and faculty talent.
  • Duke University Health System / Duke Health: Research-intensive academic medical center with a top-ranked medical school and similar scale of NIH funding, biotech industry partnerships, and translational research pipeline.
  • Washington University School of Medicine in St. Louis (WashU Medicine): Top-tier medical school with very high NIH funding per faculty, strong in neuroscience, aging, and biomedical research — directly comparable to Pitt's School of Medicine and McGowan Institute.
  • Columbia University Irving Medical Center (NewYork-Presbyterian): Academic medical center with multiple health sciences schools, deep NIH funding, and similarly large research base; comparable in scope across medicine, public health, and biomedical engineering.
  • Weill Cornell Medicine: Top-ranked medical school with NIH funding scale, strong biomedical research programs, and affiliation with a major hospital system — parallel in structure to Pitt/UPMC.
  • Mount Sinai Health System / Icahn School of Medicine: Academic medical center with comparable research enterprise, multi-school health sciences structure, and similarly strong translational research pipeline.
  • University of Michigan Medical School / Michigan Medicine: Public-university academic health sciences division with a comprehensive set of health professional schools, large externally funded research base, and broad biomedical and clinical research portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

University of Pittsburgh Health Sciences social profiles

Digital presence

University of Pittsburgh Health Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

University of Pittsburgh Health Sciences leadership team

Management profile

Number of profiles

Profiles12 records

University of Pittsburgh Health Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

University of Pittsburgh Health Sciences funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

University of Pittsburgh Health Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Pittsburgh Health Sciences

What does University of Pittsburgh Health Sciences do?

University of Pittsburgh Health Sciences delivers health sciences education across six schools (Dental Medicine, Health and Rehabilitation Sciences, Medicine, Nursing, Pharmacy, Public Health) along with biomedical and clinical research programs spanning aging, cancer immunotherapy, neuroscience, regenerative medicine, and infectious disease. Clinical services are delivered through the affiliated UPMC health system, while the McGowan Institute, Human Engineering Research Laboratories, and Pitt BioForge support technology development and commercialization.

Is University of Pittsburgh Health Sciences a public or private company?

University of Pittsburgh Health Sciences is a public company. It is classified as public and is currently operating.

When was University of Pittsburgh Health Sciences founded?

University of Pittsburgh Health Sciences was founded in 1883. It employs 5,001 to 10,000 people.

Where is University of Pittsburgh Health Sciences based?

University of Pittsburgh Health Sciences is headquartered in Pittsburgh, United States, in the North America region.

How does University of Pittsburgh Health Sciences make money?

Two revenue lines are on record. Research grants and funding is the primary driver. The others are education and training programs.

Who are University of Pittsburgh Health Sciences's main competitors?

Direct peers on record are University of Pennsylvania Health System (Penn Medicine), Johns Hopkins Medicine, UCSF Health / UCSF School of Medicine, Stanford Medicine, Duke University Health System / Duke Health, Washington University School of Medicine in St. Louis (WashU Medicine), Columbia University Irving Medical Center (NewYork-Presbyterian), Weill Cornell Medicine, Mount Sinai Health System / Icahn School of Medicine and University of Michigan Medical School / Michigan Medicine.

Does University of Pittsburgh Health Sciences have an API?

No public API is recorded for University of Pittsburgh Health Sciences.

What industry is University of Pittsburgh Health Sciences in?

University of Pittsburgh Health Sciences's product category is Academic Health Sciences Education and Research. Its primary akta.pro industry code is EDAHABAC, Health & Biomedical Research Universities (Academic Medical Center–Affiliated). Its NAICS code is 6113 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioengineeringTHINKERS: AI Combines Neural and Expert Reasoning for Lung Cancer BrainResearchers at the University of Pittsburgh Medical Center published a study in the Journal of Neuro-Oncology describing THINKERS-Lung, an AI framework that estimates local tumor failure risk and timing for lung cancer brain metastases under different Gamma Knife radiosurgery doses. Trained on 767 patients and 3,728 metastases, it achieved an AUC of 0.876 in cross-validation and 0.863 in a holdout test. The team says external validation and prospective trials are needed before clinical adoption.ForbesNew $25 Million Accelerator Bets On Better Model For Rare DiseaseThe Richard King Mellon Foundation is launching Rare Ventures, a $25 million venture philanthropy platform aimed at improving the development of treatments for rare diseases. The initiative will collaborate with several institutions, including the University of Pittsburgh Health Sciences and Stanford Medicine, and is designed to connect patient data, AI, translational science, and clinical development in a more unified system. It plans to operate across seven conditions and support hundreds of disease communities in the long term.WesanewsPittsburgh set to become rare disease research hub with $25M investmentPittsburgh is launching a new initiative focused on developing therapies for rare diseases, supported by a $25 million investment from the Richard King Mellon Foundation and involving multiple research organizations. The collaboration includes the University of Pittsburgh Health Sciences, UPMC facilities, and ElevateBio, aiming to create a venture philanthropy platform called Rare Ventures that will accelerate the development of treatments for over 10,000 rare diseases.LiebertpubExploring the Patient Experience and Perspective in Virtual-First Primary Care: A Cross-Sectional Study from an Integrated Health SystemA cross-sectional Web-based survey of 1,420 patients at University of Pittsburgh Medical Center examined early adoption and continued use of virtual-first primary care, conducted between August 2022 and January 2023. Females and patients aged 40-50 were the primary users, with 78% reporting an unimpaired physician-patient relationship, 90% saving time and 66% saving money. Only 13% said they did not want to continue using VPC.BioSpaceSimulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety SoftwareSimulations Plus, Inc. received a $1.7 million Phase II SBIR grant from the National Institutes of Health to further develop and validate its BIOLOGXsym™ quantitative systems toxicology software for macromolecule liver safety. The company will partner with the University of Pittsburgh Drug Discovery Institute to utilize its Liver-on-a-Chip platform for generating wet lab data to support the software's development over a two-year period.VC News DailyAver Informatics Raises $8.5M in Series AAver Informatics announced it has raised $8.5 million in Series A funding led by Drive Capital and GE Ventures to accelerate growth and expand its engineering and sales teams. The company, which provides a data management platform for healthcare reimbursement, also secured two new customers: University of Pittsburgh Medical Center and Molina Healthcare.